Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome

Objective : To compare the outcome of plasma exchange versus intravenous immunoglobulin among children with Guillain Barre Syndrome. Methods : A randomized controlled trial was conducted at department of Pediatrics, National Institute of Child Health, Karachi from August 2016 to February 2017. All...

Full description

Bibliographic Details
Main Authors: Erum Elahi, Muhammad Ashfaq, Bader U Nisa, Saadullah Chachar
Format: Article
Language:English
Published: Dow University of Health Sciences 2019-12-01
Series:Journal of the Dow University of Health Sciences
Subjects:
Online Access:http://www.jduhs.com/index.php/jduhs/article/view/850
_version_ 1818499697439932416
author Erum Elahi
Muhammad Ashfaq
Bader U Nisa
Saadullah Chachar
author_facet Erum Elahi
Muhammad Ashfaq
Bader U Nisa
Saadullah Chachar
author_sort Erum Elahi
collection DOAJ
description Objective : To compare the outcome of plasma exchange versus intravenous immunoglobulin among children with Guillain Barre Syndrome. Methods : A randomized controlled trial was conducted at department of Pediatrics, National Institute of Child Health, Karachi from August 2016 to February 2017. All patients of age ranged from 2-15 years of either gender having duration of Guillain Barre Syndrome not more than 14 days were included. The children were divided into plasma exchange or intravenous immunoglobulin group. Intravenous immunoglobulin was administered for five days in a dose of 0.4 g/kg/day/ while a daily one-volume plasma exchange was given to patients in the plasma exchange group for five days. Duration of mechanical ventilation and the pediatric intensive care unit stay in days were noted. Results Of 78 children, the mean age was 6.64 ±3.06 years. There were 47 (60.3%) males and 31 (39.7%) females. A significantly higher length of intensive care unit stay was noted among children who received plasma exchange (9.45 ±4.59 days) as compared to the children who received intravenous immunoglobin (4.97 ±2.84 days) (p-value <0.001, 95% CI -6.23 to -2.73). Similarly, the mean duration of ventilator stay was significantly higher among children who received plasma exchange (7.33 ±3.44 days) as compared to the children who received intravenous immunoglobin (2.01 ±0.01 days) (p-value <0.001, -7.91 to -2.74). Conclusion : The outcome of intravenous immunoglobin founds better than that of plasma exchange in treating children with Guillain Barre syndrome.
first_indexed 2024-12-10T20:32:58Z
format Article
id doaj.art-e3337c0dd94347e8b251403de6064caa
institution Directory Open Access Journal
issn 1995-2198
2410-2180
language English
last_indexed 2024-12-10T20:32:58Z
publishDate 2019-12-01
publisher Dow University of Health Sciences
record_format Article
series Journal of the Dow University of Health Sciences
spelling doaj.art-e3337c0dd94347e8b251403de6064caa2022-12-22T01:34:38ZengDow University of Health SciencesJournal of the Dow University of Health Sciences1995-21982410-21802019-12-0113313313710.36570/jduhs.2019.3.693850Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré SyndromeErum Elahi0Muhammad Ashfaq1Bader U Nisa2Saadullah Chachar3NICHNICHNICHNICHObjective : To compare the outcome of plasma exchange versus intravenous immunoglobulin among children with Guillain Barre Syndrome. Methods : A randomized controlled trial was conducted at department of Pediatrics, National Institute of Child Health, Karachi from August 2016 to February 2017. All patients of age ranged from 2-15 years of either gender having duration of Guillain Barre Syndrome not more than 14 days were included. The children were divided into plasma exchange or intravenous immunoglobulin group. Intravenous immunoglobulin was administered for five days in a dose of 0.4 g/kg/day/ while a daily one-volume plasma exchange was given to patients in the plasma exchange group for five days. Duration of mechanical ventilation and the pediatric intensive care unit stay in days were noted. Results Of 78 children, the mean age was 6.64 ±3.06 years. There were 47 (60.3%) males and 31 (39.7%) females. A significantly higher length of intensive care unit stay was noted among children who received plasma exchange (9.45 ±4.59 days) as compared to the children who received intravenous immunoglobin (4.97 ±2.84 days) (p-value <0.001, 95% CI -6.23 to -2.73). Similarly, the mean duration of ventilator stay was significantly higher among children who received plasma exchange (7.33 ±3.44 days) as compared to the children who received intravenous immunoglobin (2.01 ±0.01 days) (p-value <0.001, -7.91 to -2.74). Conclusion : The outcome of intravenous immunoglobin founds better than that of plasma exchange in treating children with Guillain Barre syndrome.http://www.jduhs.com/index.php/jduhs/article/view/850plasma exchangeintravenous immunoglobulinchildren, guillain barré syndrome
spellingShingle Erum Elahi
Muhammad Ashfaq
Bader U Nisa
Saadullah Chachar
Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
Journal of the Dow University of Health Sciences
plasma exchange
intravenous immunoglobulin
children, guillain barré syndrome
title Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
title_full Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
title_fullStr Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
title_full_unstemmed Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
title_short Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
title_sort plasma exchange versus intravenous immunoglobulin in children with guillain barre syndrome
topic plasma exchange
intravenous immunoglobulin
children, guillain barré syndrome
url http://www.jduhs.com/index.php/jduhs/article/view/850
work_keys_str_mv AT erumelahi plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome
AT muhammadashfaq plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome
AT baderunisa plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome
AT saadullahchachar plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome